AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2690-8808/254
1University of Eswatini, Faculty of Health Sciences, Department of Environmental Health Sciences;
2National Malaria Programme, Kingdom of Eswatini.
*Corresponding Author: Sabelo Vusi Dlamin, University of Swaziland, Faculty of Health Sciences, P.O. Box 369, Mbabane, Eswatini.
Citation: Sabelo V. Dlamini, Mathobela Mbongiseni, Nxumalo Sihle, Hlope Londiwe, (2025), Routine Malaria Control During the Covid-19 Pandemic in The Kingdom of Eswatini: A Benefit-Risk Analysis of Health Benefits Versus Excess Risk of Sars-Cov-2 Infection, J, Clinical Case Reports and Studies, 6(4); DOI:10.31579/2690-8808/254
Copyright: ©, 2025, Sabelo Vusi Dlamin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 04 April 2025 | Accepted: 13 May 2025 | Published: 20 May 2025
Keywords: malaria; plasmodium falciparum; and covid-19; SARS-COV-2; malaria elimination
Introduction: The ongoing COVID-19 pandemic is the most sustained disruptive and lethal disease outbreak since the 1918 influenza pandemic. As witnessed globally, the COVID-19 pandemic has the potential to overburden health systems and delay achievement of set targets for elimination or control. Discovery and implementations of effective treatments and/or vaccines for SARS-CoV-2 would reduce the duration and intensity of social distancing required to maintain control of the COVID-19 pandemic. The substantial progress made by the Kingdom of Eswatini in reducing the malaria burden could be jeopardised by the current COVID-19 pandemic. This study aims to describe potential effects of the COVID-19 pandemic on malaria incidence in the Kingdom of Eswatini.
Methods: This study employed a retrospective analytical study using monthly malaria morbidity data on the overall number of outpatients. Confirmed malaria cases were extracted from the National Malaria Programme database derived from routine passive reported malaria cases in health facilities and from reactive case detected malaria. Malaria diagnosis was based either on the results of rapid diagnostic tests or microscopy. The data have been processed with Microsoft Excel Version 16.52 and analysed with Stata IC Version 16 (Stata-Corp, College Station, TX, USA).
Findings: During March 2020, the number of confirmed malaria cases in Eswatini increased by 107% in March 2020 when the RSA, Mozambique and the Kingdom of Eswatini announced implementation of the first lockdown and travel restrictions. A majority of the cases confirmed in March were local cases, contrary to previous reports where imported cases were among the majority of cases reported in the country during each transmission season. The increase of cases in March 2020 suggests that intervention measures were implemented at reduced levels due to COVID-19 restrictions.
Conclusion
Neglecting malaria control interventions during the COVID-19 pandemic could prove catastrophic for malaria elimination in Eswatini. Malaria could develop into a scenario worse off than COVID-19 if neglected. Diagnosis for COVID-19 could be coupled with malaria diagnosis to avoid missing malaria cases during the COVID-19 pandemic.
The Kingdom of Eswatini is located in a part of sub-Saharan Africa (SSA) that is endemic with malaria and one that bears the brunt of the global mortality rates of 400 000 deaths and 200 million cases in 2018 [1]. The scaling up of Indoor residual spraying (IRS) and distribution of long-lasting insecticide treated nets (LLINs), introduction of rapid diagnostic tests (RDTs) and effective treatment with artemisinin-based combination therapies have resulted in significant reductions of morbidity and mortality due to malaria in the Kingdom of Eswatini. However, the introduction and spread of the COVID-19 pandemic has had a negative impact on many public health gains and threatens to bring public health interventions in low-income countries to a collapse. Many sub-Saharan African countries are faced with saturation of health systems that are likely to expose pre-existing fragilities and exacerbate the myriad health problems afflicting human populations. Recognition of the threat posed to malaria control by COVID-19 has been widespread [2], and many countries have made attempts to contextualise these threats amid evolving global health priorities. Progress towards the 2020 milestones of the WHO global malaria strategy was reported to be substantially off track. In 2020, the global malaria case incidence rate was 59 cases per 1000 people at risk against a target of 35 — putting it off track by 40% [3]. The global mortality rate was 15.3 deaths per 100 000 people at risk against a target of 8.9 — putting it off track by 42%. Reaching the 2030 goals of the WHO malaria elimination strategy, including a 90% reduction in global malaria incidence and mortality rates by 2030, will require new approaches, new tools and the better implementation of existing ones [3]. The World Health Organization’s malaria strategy emphasizes the need to carefully tailor existing approaches to prevention, diagnosis and treatment to local contexts, and to strengthen health systems overall, with a view to achieving universal health coverage.
As of 28 May 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had infected more than 5·85 million individuals worldwide and caused more than 359 000 deaths [4]. On March 11, 2020, the World Health Organisation (WHO) officially declared the COVID-19 pandemic to be a public health emergency of international concern [5]. The first case of COVID-19 was reported on 14 March, 2020 in Eswatini. As of 16 November, 2020 at least 6 095 cases had been confirmed and 119 deaths reported. Globally, COVID-19 has the potential to overburden health systems and contribute to the prevention of access to essential healthcare. Compared with responses to COVID-19 in high-income countries, however, the measures taken in Eswatini have come amid the backdrop of more acute health-system resource limitations and persistently higher burdens of other infectious diseases such as HIV/AIDS and tuberculosis. Emergency lockdowns were initiated in countries across the globe, and the effect on health, wellbeing, business, and other aspects of daily life were felt throughout societies and by individuals. With no effective pharmacological interventions or vaccine available in the imminent future, reducing the rate of infection (i.e. flattening the curve) was a priority, and prevention of infection was the best approach to achieve this aim. Whilst the national shutdown measures to help curb the spread of the virus resulted in widespread inconvenience, it created an unprecedented public health opportunity as well. It has long been hypothesized that interruption in the movement of infected persons (and, therefore, malaria parasites) across borders would impact the malaria elimination trajectory by reducing importation pressure on receptive areas [6]. However, the COVID-19 pandemic represents a new threat to malaria service delivery. As the virus begins to spread in malaria-endemic countries, including many sub-Saharan African countries, their fragile health systems will likely be overwhelmed. Indeed, the recent Ebola outbreak in West Africa demonstrated that a sudden increase in demand for health services can lead to substantial increases in morbidity and mortality from other diseases, including malaria.
This study aims to describe potential effects of the COVID-19 pandemic on malaria incidence in the Kingdom of Eswatini, both from locally transmitted and imported source.
This study employed a retrospective exploratory study using monthly malaria morbidity data on the overall number of confirmed outpatients. Confirmed malaria cases were extracted from the National Malaria Programme database derived from routine follow-up of passively reported malaria cases in health facilities. Malaria diagnosis was based either on the results of rapid diagnostic tests or microscopy. Total numbers of confirmed malaria cases between the transmission seasons 2015/16 and 2020/21 were sourced from records of the National Malaria Programme (NMP). CIVID-19 data was sourced from achieved data from the Epidemiology and Disease Control Unit (EDCU). Both malaria and COVID-19 are notifiable diseases and health facilities that confirm diagnosis of these diseases are required to complete notification forms and report their diagnosis to the Ministry of Health and to the EDCU or the NMP. The data have been processed with Microsoft Excel Version 16.52 and analysed with Stata IC Version 16 (Stata-Corp, College Station, TX, USA).
Confirmed malaria cases were on the increase in Eswatini until 2017 when the country and the region received higher than normal rains, hence the increase in number of cases reported across the region. The National Malaria Programme timely implemented indoor residual spray (IRS), appropriate diagnosis and disease management among patients confirmed to be infected through rapid diagnostic test (RDTs), microscopy and treatment of uncomplicated cases with artemether-lumefantrine. The country also introduced chemoprophylaxis to travellers visiting malaria endemic areas, especially Mozambique, in order to prevent importation of parasites. The country also implemented reactive case detection through the screening and treatment of persons within 500m radius of the households of an identified case. The surveillance unit of the NMP, upon receipt of notification of a malaria case, would follow it up to its locality and implement control measures in that area, including IRS in all the homesteads and the treatment of those screened and found to be positive. These implemented strategies proved to be successful in moving the country towards elimination of malaria within the foreseeable future. These initiatives resulted to reduced malaria incidence between the 2017/18 and the 2019/2020 transmission seasons i.e. before introduction of COVID-19 and the implementation of strategies to reduce its spread in the country (Fig. 1).
Figure 1: Total Confirmed Malaria Cases (Local and Imported) by Transmission Season 2015/16 to 2019/20
The number of confirmed malaria cases from July to June for the transmission seasons 2018/19 and 2019/20 were broken down by month. The results suggest that there were higher numbers of malaria confirmed cases in July, November and December 2018/19 transmission season compared to the same period in the 2019/20 season. However, this was before COVID-19 was reported in the Kingdom of Eswatini. Therefore, this difference could be due to other reasons and not COVID-19. The reduction of cases in 2019 was probably due to timely implementation of indoor residual spray in 2019. A significantly higher number of cases were recorded in March 2020 compared to March 2019 (Fig. 2). This period recorded a 106.8% increase in number of cases between the 2018/19 and the 2019/20 transmission seasons. March 2020 coincides with the start of the partial lockdown period as a response to contain the COVID-19 pandemic that had been reported in the Kingdom of Eswatini and among neighbouring countries. During the partial lockdown, all borders between South Africa and Mozambique were closed between 26 March, 2020 and 29 December, 2020 and local travel was significantly restricted in the Kingdom of Eswatini. This restriction included malaria personnel travelling to outreach areas and health facilities to implement control measures e.g. the movement of spray teams that routinely conduct indoor residual spraying at malaria endemic areas in the country was restricted.
Figure 2: Total Confirmed Cases (Local & Imported) by Month (July 2018 – June 2020)
The number of confirmed malaria cases for the transmission seasons July 2018 – June 2019 and July 2019 to June 2020 were broken down by local versus imported cases. The results suggest that local transmission was dominant in the months of March and April. The programme had to halt proactive community screening in response to COVID-19 regulations implemented in March 2020. The number of confirmed local malaria cases was significantly higher in March 2020 compared with March 2019, 93 versus 34 cases, respectively (Fig. 3). The return of Swazi nationals working or visiting neighbouring countries such as Mozambique, with high malaria incidence, could partly account for the high number of malaria cases reported in March 2020. In March, 2020, the country imposed a partial lock-down which forced many locals to return to the country to stay at their homes. Those infected returned with parasites that initiated local transmissions. The disruption of control interventions due to COVID-19 restrictions partly contributed to reduced implementation of control measures, especially along border areas and within communities.
Figure 3: Number of Confirmed Local Malaria Cases in Eswatini by season, July 2018/19 to June 2019/20
Testing of community members for malaria is only done reactively following passive confirmation of local cases by health facilities, and only those with immediate risk are targeted. However, following the implementation of partial lockdown in response to COVID-19 spread, reactive testing of community members and implementation of measures around a confirmed case were halted, resulting in increased local transmission. This phenomenon partly explains the increase of local cases after the pronunciation of restricted movement during the COVID-19 response.
The majority of confirmed cases of malaria in the Kingdom of Eswatini are usually from imported sources. The country routinely reports a high number of imported cases in January, following the festive season and in May, after the Easter holidays. Increases are usually due to returning residents that are citizens of Mozambique but who are employed in the country. Locals who also visit malaria endemic areas during the holidays return with malaria parasites and are recorded as imported cases since the disease is contracted externally. Following pronunciation of partial lockdown in March 2020, the number of local cases increased between February and March (OR=2.44, p=0.0079). Imported cases then initiate local transmission in areas where inadequate control measures have not been put in place. However, our data suggests that, following the ban of international travel, imported cases were lower between January and June in 2020 compared to the same period in 2019 (Fig 4). A reduction of 54.5% of imported cases was observed in January. In April and May 2020, reduction rates of 90.5% and 96.8% respectively when compared to the same months in 2019 were observed.
Figure 4: Confirmed imported malaria cases in Eswatini by season, July 2018 to June 2019 and July 2019 to June 2020
The total confirmed imported malaria cases increased between December and January (OR=0.22, p=0.0016), both in the 2018/19 and 2019/20 transmission season as has been the norm. However, in February and March 2020, the number of imported cases suggest that there was a decrease even though this does not appear to be a significant decrease (OR=2.19, OR=0.13), but imported cases continued to decrease from February to May 2020/21 season compared to the number of cases reported for the same months in 2018/19 and 2019/20 (Figure.5A). On a positive note on malaria importation, the COVID-19 regulations imposed travel restrictions in personnel travelling from other countries, some of which may be high malaria endemic regions in the continent or between endemic parts of the country and non-endemic parts. For these reasons, imported malaria was significantly lower in January in the 2019/20 and 2020/21 transmission seasons compared to the same transmission season in 2018/19 (Figure.5C). However, the number of indigenous cases was significantly higher in April and May 2020/21 compared to the same period in 2018/19 and 2019/20 when the country reported a sharp increase of indigenous cases between February and May (Figure.5B). The percentage difference increased considerably from 43% in December 2019 to 733% in May 2020 and this increase is congruent with the period of introduction of COVID-19 and implementation of measures to prevent spread of the pandemic.
Figure 5: Monthly confirmed (indigenous + imported) malaria cases
Particularly following implementation of the partial lockdown in March 2020, confirmed local cases increased by 748% in April and 733% in May. This could be due to locals returning from endemic areas with infections following pronouncement of the partial lockdown. Returning residents may have carried parasites and initiated local transmission without any interventions to halt such. Disruption in ITN distribution, indoor residual spray and reactive case detection could likely explain these unusual increases.
Data on sprayed structures was examined for four transmission seasons (2017/18 to 2021/22) (Fig.6) and, while efforts resulted in increased structures sprayed in 2020, the proportion significantly decreased in 2021/22 (OR=1.16 95% CI 1.11 – 1.21), p<0>
The COVID-19 pandemic has strained healthcare delivery systems in a number of southern African countries. Despite this, it is imperative that malaria control and elimination activities continue, especially to reduce as far as possible the number and rate of hospitalisations caused by malaria and to ensure gains on elimination targets are not lost. The implementation of enhanced malaria control/elimination activities in the context of COVID-19 requires measures to protect healthcare workers and the communities they serve. The challenges of coping with curbing the spread of COVID-19 while routinely implementing malaria control strategies placed major challenges and burdens in the Eswatini’s health system. The findings reported in our study are in agreement with modelling estimates which suggested that, given worst- case scenarios of disruptions of malaria interventions, including IRS and ITNs, there could be four-fold increase in malaria mortality in the sub-Saharan region within 2020 than malaria deaths reported globally in 2000 [3]. The country reported higher numbers of confirmed local and imported malaria cases in March 2020 compared to March 2019, which coincides with announcement of the beginning of the partial lockdown implemented to curb the spread of COVID-19 in the country. These findings are consistent with reports of significant spikes elsewhere during implementation of the lockdown in response to COVID-19 [7]. During the outbreak of Ebola virus in a multi-country epidemic in 2014-15 in parts of West Africa, malaria deaths increased significantly and exceeded the number of deaths from Ebola virus [8, 9]. The increase was attributed to decrease in antimalarial drug administration, reduced healthcare capacity and cessation of rapid diagnostic testing [10,11,12]. The experiences from Ebola should be taken into consideration during the COVID-19 predicament. This experience suggests that, it may pose danger of significant magnitude to focus on prevention COVID-19 spread while ignoring malaria control which may result in severe disease and increase death rates worse off than the new epidemic. The Kingdom of Eswatini, through the Global Fund for HIV/AIDS, Tuberculosis and Malaria (GFATM), has invested millions of dollars in the fight against malaria, to the point that, in 2011, a policy for the elimination of malaria was adopted following several years when malaria incidence remained considerably low. Neglecting control measures for malaria, even only for a few months, could result in Eswatini losing the gains that had been achieved towards maintaining control of malaria and the strides made towards elimination. The WHO recommends that malaria control processes should remain intact during COVID-19 travel restrictions. This recommendation suggests that all the resources required to fight malaria, including human and material resources should be in place and not be tempered with during the fight against new emergent diseases such as COVID-19, Ebola, etc.
Malaria Control Resources
The global push to accelerate progress in malaria control was made possible by a substantial increase in international funding from partners such as GFATM, Bill and Melinda Gates Foundation, the President’s Malaria Initiative and others. The recent slowdown in progress towards malaria elimination has been accompanied by a plateauing of international funding, leading to concerns that financing may be a constraint to accelerating progress to malaria elimination even before the introduction of SARS-CoV-2. At the same time, there were concerns about the impact of the global financing architecture to the effectiveness of malaria control and elimination at the country level. Despite the total investment funding for malaria control and elimination being successively increased from 2018 to 2020, constituting USD 2.7 billion in 2018 [1], USD 3.0 billion in 2019 [13], and USD 3.3 billion in 2020 [14], there was an expected financial gap of approximately USD 6.8 billion in 2020 compared to the goal [14]. Despite the focus on international funding, the reality is that domestic financing for malaria from government and private sources has been far greater. The financial contribution of developing countries is systematically under-counted because most efforts to track malaria financing only consider programmatic spending by malaria control programmes, and do not consider the larger spending by general health services, which also includes private expenditures by households. Therefore, despite the Global Fund’s efforts and other funding agents, to alleviate country funding gaps, the reallocation of country resources towards the fight against COVID-19 undermines the effort. Reports suggest there was a significant gap in financing malaria control globally, which imposed a significant burden on the economies of many Sub-Saharan African countries [15]. During COVID-19, many of the country’s limited resources were reallocated to the response of curbing the potential COVID-19 catastrophe. Motor vehicles used for many disease control processes including those for the malaria control and elimination were re-deployed towards curbing the COVID-19 threat. Meeting global targets will require robust funding while current funding levels (estimated at US$3.3 billion in 2020) will need to more than triple, reaching US$ 10.3 billion per year by 2030 in order to also offset financial challenges resultant from the COVID-19 depletion of many countries’ financial positions. The Global Fund provides 56% of all international financing for malaria programmes and had invested more than US$14.7 billion in malaria control programmes as of June 2021. Since 2020, the Global Fund had also stepped up to support countries to mitigate the impact of COVID-19 on the malaria response. From January 2021, the Global Fund had increased malaria grants by 23% on average, expressed committed to deploying about US$4 billion to fight the disease over the next three years. Such contributions, however, have contributed to sustained fight against malaria but, still fall short of the required amounts especially with some of these funds reprioritised towards fighting COVID-19 in low- and middle-income countries including Eswatini. Nevertheless, COVID-19 has disproportionately affected developed countries, threatening their capacity to make donations towards funding malaria control in low and middle-income countries.
Malaria Surveillance
It has become apparent with improved surveillance and case investigation that imported malaria, deriving almost entirely from Mozambique (greater than 90%) [16], drives malaria transmission in Eswatini. It was shown that patients identified through passive surveillance and classified as imported cases by the Eswatini NMP have networks of contacts who can easily be reached and screened for malaria infection [17]. Patients with fever may get tested for COVID-19 and sent home due to a negative result when they may, in fact, have malaria infection and vice versa, thereby preventing implementation of case investigation. Also, laboratory-confirmed cases of both asymptomatic malaria and COVID-19 infected individuals have been reported. This increases the possibility that both asymptomatic patients can transmit the infection through their respective modes [18, 19].
Vector Control Operations
During the era of pre-elimination of malaria, the country resorted to deliver IRS annually before the beginning of each transmission season. Implementation of IRS in malaria endemic parts of the country and in foci where a malaria case (or cases) had been identified required workers to enter houses to spray the inner walls. The scaling up of indoor residual sprays was the main driver for reduced malaria incidence in Eswatini. However, during COVID-19, such action was viewed as invasive by householders and the safety of the householders from contracting COVID-19 from any visitor was viewed to be more important than malaria. Also, due to implementation of the COVID-19 regulations, which emphasized physical distancing and travel restrictions, disruptions in the supply chains for IRS materials and insecticides were experienced. During the COVID-19 pandemic, IRS operations were also hindered by reallocation of limited resources to COVID-19 response and disruptions in the supply chain of IRS insecticides. Modelling has estimated that, given worst-case scenarios of disruptions of malaria interventions, including ITN and IRS, there could be up to a fourfold increase in malaria mortality in the African region within the next year or more malaria deaths in 2020 than all malaria deaths reported globally in 2000 [3,20]. Mozambique, a country that has direct influence of imported malaria into the Kingdom of Eswatini, had scheduled both IRS and ITN in 2020, yet these campaigns were delayed because of COVID-19 restrictions. The NMCP in Mozambique had planned to distribute 20.9 million ITNs, to provide protection to almost 70% of its population at risk of malaria [21]. Failure to implement and achieve this target could suggest that Mozambicans that lived in Eswatini would return with malaria parasites when the lockdown period ended and travel restrictions were lifted. In Nigeria, a country with the highest malaria-at-risk population in sub-Saharan Africa (SSA) (>200 million) could only manage to distribute 11.2% of the 22.7 million ITNs planned for distribution during 2020 [22]. Overall, in SSA, more than 34 million people were denied access to the lifesaving ITNs during the COVID-19 disruptions. However, the Eswatini NMP could not intricately convey the difficulties it faced when implementing malaria vector control programmes during COVID-19. Hence, our study may have grossly underscored the true picture of the challenges faced by the programme.
Prompt diagnosis, reporting and surveillance
The gains in reduced transmission of malaria in Eswatini has been partly due to constant passing on of messages to the public to promptly identify malaria related symptoms and visit the nearest health facilities, where healthcare workers were also trained to suspect and test for malaria on any patient reporting with fever. The symptoms of COVID-19 are similar to those shown by patients with malaria, especially fever, headache and other flu-like symptoms, thereby complicating differential diagnosis. During COVID-19, many individuals that experienced fever immediately thought of COVID-19 and not malaria. Attending healthcare personnel also tested for COVID-19 among presenting patients and ignored the routine testing for malaria among fever patients, resulting in malaria infected patients being missed, leading to some malaria cases being untreated. COVID-19 messages, especially during the lockdown period, discouraged clients to attend health facilities in strict contradiction to malaria messages of seeking treatment at the onset of suspicious symptoms. In addition, COVID-19 deaths instilled fear of infection with the rampant coronavirus among malaria symptomatic individuals who would have adhered to the call for prompt visit to health facilities. This probably explains the decreased malaria testing in health facilities during the lockdown period. The market for malaria rapid diagnostic tests was also disrupted by increased demand for COVID-19 tests making it difficult for the country to get its supplies timeously and in adequate amounts.
Experience from several developed nations such as the United States, Italy and China have demonstrated beyond reasonable doubt that COVID-19 can overwhelm even well-established healthcare systems [23, 24]. Modelling approaches have suggested that SARS-CoV-2 will enter into long-term circulation alongside other beta-coronaviruses, possibly in annual, biennial or sporadic patterns [25]). If the development of appropriate treatments or effective vaccines continue to delay, (including the uptake of the vaccines), it suggests that countries with malaria elimination ambitions and targets will have only the current strategies (physical distancing, enforcing the wearing of face masks, promotion of hand-washing with soap and water or disinfecting with 70% alcohol-based sanitizers) to contain spread of coronavirus. However, several countries have experienced severe transmission peaks despite implementation of these strategies because they all largely depend on change of social habits. Therefore, it means countries like Eswatini will have to strengthen adherence to the current COVID-19 regulations if gains made in the past years of malaria control will have to be preserved. Also, the country will have to quickly make available resources (human, financial, vehicles, etc) specifically to fight the spread of COVID-19 to prevent redeployment of resources reserved for other public health interventions such as malaria control and elimination. We also take note of the economic implications of continued social distancing with potentially catastrophic effects on businesses, households and the healthcare system itself. Better policies will have to be developed to ensure the economy survives within the new norms dictated by the constant presence and spread of COVID-19 or its reoccurrence in the public.
The available tools have been considered adequate to drive the malaria elimination agenda to completion by 2025 in the Kingdom of Eswatini. However, the introduction of COVID-19 into the country early in 2020 threatens to disturb the country’s health systems towards achievement of this long term goal. Swift policy actions could substantially reduce the burden of malaria and COVID-19 epidemics simultaneously overwhelming the vulnerable health systems of the country. The country should consider testing fever patients suspected to be infected with SARS-CoV-2 for both malaria and COVID-19. Failure to implement effective strategies to maintain COVID-19 suppression is likely to lead to a large resurgence of COVID-19 transmissions, potentially resulting in worse outcomes for both COVID-19 and malaria. The risk of malaria resurgence often remains high in the country, particularly in view of the fact that a majority of cases are imported from neighbouring countries with high endemicity. Such scenarios are likely to lead to reduction of the gains achieved earlier in controlling malaria and targeting elimination in 2025. The commitment from the country’s government, funding agencies and non-governmental organisations for adequate funding of malaria control and elimination programmes is instrumental during and after the COVID-19 pandemic. The major problem is that no one knows how long the COVID-19 pandemic will last, hence we must devise strategies to continue other disease control programmes while dealing with the pandemic. The WHO Global Malaria Programme (GMP) has also worked with several modelling teams to analyse the potential impact on malaria burden of different service disruption scenarios. The outputs of these modelling exercises reinforced the message that country programmes and ministries of health must ensure the continuity of malaria prevention and treatment services during the response to COVID-19. If anything, the COVID-19 pandemic has provided good lessons for when other similar pandemics arrive while malaria elimination is still an issue, and should remain a priority. Also, in 2020, the World Health Organisation released guidelines for malaria control in areas affected by COVID-19 [26]. The guidelines advice countries on strategies to implement while continuing with all the routine malaria control measures while adhering to COVID-19 local personal and physical distancing guidelines established by the authorities. Adherence to these guidelines could prevent loss of gains towards malaria elimination while also ensuring minimal morbidity and mortality due to COVID-19.
This work did not receive any specific funding from agencies in the public health, commercial, or not-for-profit organisations.
The authors declare that they have no known competing interests or personal relationships that could have appeared to influence the work reported in this paper.
This study was carried out in the technical support framework of malaria surveillance, in the ambit of the COVID-19 emergency, ethical clearance was not necessary, and the malaria data analysed were grouped and did not involve Individual identification.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.
My experience publishing in Psychology and Mental Health Care was exceptional. The peer review process was rigorous and constructive, with reviewers providing valuable insights that helped enhance the quality of our work. The editorial team was highly supportive and responsive, making the submission process smooth and efficient. The journal's commitment to high standards and academic rigor makes it a respected platform for quality research. I am grateful for the opportunity to publish in such a reputable journal.
My experience publishing in International Journal of Clinical Case Reports and Reviews was exceptional. I Come forth to Provide a Testimonial Covering the Peer Review Process and the editorial office for the Professional and Impartial Evaluation of the Manuscript.
I would like to offer my testimony in the support. I have received through the peer review process and support the editorial office where they are to support young authors like me, encourage them to publish their work in your esteemed journals, and globalize and share knowledge globally. I really appreciate your journal, peer review, and editorial office.
Dear Agrippa Hilda- Editorial Coordinator of Journal of Neuroscience and Neurological Surgery, "The peer review process was very quick and of high quality, which can also be seen in the articles in the journal. The collaboration with the editorial office was very good."
I would like to express my sincere gratitude for the support and efficiency provided by the editorial office throughout the publication process of my article, “Delayed Vulvar Metastases from Rectal Carcinoma: A Case Report.” I greatly appreciate the assistance and guidance I received from your team, which made the entire process smooth and efficient. The peer review process was thorough and constructive, contributing to the overall quality of the final article. I am very grateful for the high level of professionalism and commitment shown by the editorial staff, and I look forward to maintaining a long-term collaboration with the International Journal of Clinical Case Reports and Reviews.
To Dear Erin Aust, I would like to express my heartfelt appreciation for the opportunity to have my work published in this esteemed journal. The entire publication process was smooth and well-organized, and I am extremely satisfied with the final result. The Editorial Team demonstrated the utmost professionalism, providing prompt and insightful feedback throughout the review process. Their clear communication and constructive suggestions were invaluable in enhancing my manuscript, and their meticulous attention to detail and dedication to quality are truly commendable. Additionally, the support from the Editorial Office was exceptional. From the initial submission to the final publication, I was guided through every step of the process with great care and professionalism. The team's responsiveness and assistance made the entire experience both easy and stress-free. I am also deeply impressed by the quality and reputation of the journal. It is an honor to have my research featured in such a respected publication, and I am confident that it will make a meaningful contribution to the field.
"I am grateful for the opportunity of contributing to [International Journal of Clinical Case Reports and Reviews] and for the rigorous review process that enhances the quality of research published in your esteemed journal. I sincerely appreciate the time and effort of your team who have dedicatedly helped me in improvising changes and modifying my manuscript. The insightful comments and constructive feedback provided have been invaluable in refining and strengthening my work".
I thank the ‘Journal of Clinical Research and Reports’ for accepting this article for publication. This is a rigorously peer reviewed journal which is on all major global scientific data bases. I note the review process was prompt, thorough and professionally critical. It gave us an insight into a number of important scientific/statistical issues. The review prompted us to review the relevant literature again and look at the limitations of the study. The peer reviewers were open, clear in the instructions and the editorial team was very prompt in their communication. This journal certainly publishes quality research articles. I would recommend the journal for any future publications.
Dear Jessica Magne, with gratitude for the joint work. Fast process of receiving and processing the submitted scientific materials in “Clinical Cardiology and Cardiovascular Interventions”. High level of competence of the editors with clear and correct recommendations and ideas for enriching the article.
We found the peer review process quick and positive in its input. The support from the editorial officer has been very agile, always with the intention of improving the article and taking into account our subsequent corrections.
My article, titled 'No Way Out of the Smartphone Epidemic Without Considering the Insights of Brain Research,' has been republished in the International Journal of Clinical Case Reports and Reviews. The review process was seamless and professional, with the editors being both friendly and supportive. I am deeply grateful for their efforts.
To Dear Erin Aust – Editorial Coordinator of Journal of General Medicine and Clinical Practice! I declare that I am absolutely satisfied with your work carried out with great competence in following the manuscript during the various stages from its receipt, during the revision process to the final acceptance for publication. Thank Prof. Elvira Farina
Dear Jessica, and the super professional team of the ‘Clinical Cardiology and Cardiovascular Interventions’ I am sincerely grateful to the coordinated work of the journal team for the no problem with the submission of my manuscript: “Cardiometabolic Disorders in A Pregnant Woman with Severe Preeclampsia on the Background of Morbid Obesity (Case Report).” The review process by 5 experts was fast, and the comments were professional, which made it more specific and academic, and the process of publication and presentation of the article was excellent. I recommend that my colleagues publish articles in this journal, and I am interested in further scientific cooperation. Sincerely and best wishes, Dr. Oleg Golyanovskiy.
Dear Ashley Rosa, Editorial Coordinator of the journal - Psychology and Mental Health Care. " The process of obtaining publication of my article in the Psychology and Mental Health Journal was positive in all areas. The peer review process resulted in a number of valuable comments, the editorial process was collaborative and timely, and the quality of this journal has been quickly noticed, resulting in alternative journals contacting me to publish with them." Warm regards, Susan Anne Smith, PhD. Australian Breastfeeding Association.
Dear Jessica Magne, Editorial Coordinator, Clinical Cardiology and Cardiovascular Interventions, Auctores Publishing LLC. I appreciate the journal (JCCI) editorial office support, the entire team leads were always ready to help, not only on technical front but also on thorough process. Also, I should thank dear reviewers’ attention to detail and creative approach to teach me and bring new insights by their comments. Surely, more discussions and introduction of other hemodynamic devices would provide better prevention and management of shock states. Your efforts and dedication in presenting educational materials in this journal are commendable. Best wishes from, Farahnaz Fallahian.
Dear Maria Emerson, Editorial Coordinator, International Journal of Clinical Case Reports and Reviews, Auctores Publishing LLC. I am delighted to have published our manuscript, "Acute Colonic Pseudo-Obstruction (ACPO): A rare but serious complication following caesarean section." I want to thank the editorial team, especially Maria Emerson, for their prompt review of the manuscript, quick responses to queries, and overall support. Yours sincerely Dr. Victor Olagundoye.
Dear Ashley Rosa, Editorial Coordinator, International Journal of Clinical Case Reports and Reviews. Many thanks for publishing this manuscript after I lost confidence the editors were most helpful, more than other journals Best wishes from, Susan Anne Smith, PhD. Australian Breastfeeding Association.
Dear Agrippa Hilda, Editorial Coordinator, Journal of Neuroscience and Neurological Surgery. The entire process including article submission, review, revision, and publication was extremely easy. The journal editor was prompt and helpful, and the reviewers contributed to the quality of the paper. Thank you so much! Eric Nussbaum, MD
Dr Hala Al Shaikh This is to acknowledge that the peer review process for the article ’ A Novel Gnrh1 Gene Mutation in Four Omani Male Siblings, Presentation and Management ’ sent to the International Journal of Clinical Case Reports and Reviews was quick and smooth. The editorial office was prompt with easy communication.
Dear Erin Aust, Editorial Coordinator, Journal of General Medicine and Clinical Practice. We are pleased to share our experience with the “Journal of General Medicine and Clinical Practice”, following the successful publication of our article. The peer review process was thorough and constructive, helping to improve the clarity and quality of the manuscript. We are especially thankful to Ms. Erin Aust, the Editorial Coordinator, for her prompt communication and continuous support throughout the process. Her professionalism ensured a smooth and efficient publication experience. The journal upholds high editorial standards, and we highly recommend it to fellow researchers seeking a credible platform for their work. Best wishes By, Dr. Rakhi Mishra.
Dear Jessica Magne, Editorial Coordinator, Clinical Cardiology and Cardiovascular Interventions, Auctores Publishing LLC. The peer review process of the journal of Clinical Cardiology and Cardiovascular Interventions was excellent and fast, as was the support of the editorial office and the quality of the journal. Kind regards Walter F. Riesen Prof. Dr. Dr. h.c. Walter F. Riesen.
Dear Ashley Rosa, Editorial Coordinator, International Journal of Clinical Case Reports and Reviews, Auctores Publishing LLC. Thank you for publishing our article, Exploring Clozapine's Efficacy in Managing Aggression: A Multiple Single-Case Study in Forensic Psychiatry in the international journal of clinical case reports and reviews. We found the peer review process very professional and efficient. The comments were constructive, and the whole process was efficient. On behalf of the co-authors, I would like to thank you for publishing this article. With regards, Dr. Jelle R. Lettinga.
Dear Clarissa Eric, Editorial Coordinator, Journal of Clinical Case Reports and Studies, I would like to express my deep admiration for the exceptional professionalism demonstrated by your journal. I am thoroughly impressed by the speed of the editorial process, the substantive and insightful reviews, and the meticulous preparation of the manuscript for publication. Additionally, I greatly appreciate the courteous and immediate responses from your editorial office to all my inquiries. Best Regards, Dariusz Ziora
Dear Chrystine Mejia, Editorial Coordinator, Journal of Neurodegeneration and Neurorehabilitation, Auctores Publishing LLC, We would like to thank the editorial team for the smooth and high-quality communication leading up to the publication of our article in the Journal of Neurodegeneration and Neurorehabilitation. The reviewers have extensive knowledge in the field, and their relevant questions helped to add value to our publication. Kind regards, Dr. Ravi Shrivastava.
Dear Clarissa Eric, Editorial Coordinator, Journal of Clinical Case Reports and Studies, Auctores Publishing LLC, USA Office: +1-(302)-520-2644. I would like to express my sincere appreciation for the efficient and professional handling of my case report by the ‘Journal of Clinical Case Reports and Studies’. The peer review process was not only fast but also highly constructive—the reviewers’ comments were clear, relevant, and greatly helped me improve the quality and clarity of my manuscript. I also received excellent support from the editorial office throughout the process. Communication was smooth and timely, and I felt well guided at every stage, from submission to publication. The overall quality and rigor of the journal are truly commendable. I am pleased to have published my work with Journal of Clinical Case Reports and Studies, and I look forward to future opportunities for collaboration. Sincerely, Aline Tollet, UCLouvain.
Dear Ms. Mayra Duenas, Editorial Coordinator, International Journal of Clinical Case Reports and Reviews. “The International Journal of Clinical Case Reports and Reviews represented the “ideal house” to share with the research community a first experience with the use of the Simeox device for speech rehabilitation. High scientific reputation and attractive website communication were first determinants for the selection of this Journal, and the following submission process exceeded expectations: fast but highly professional peer review, great support by the editorial office, elegant graphic layout. Exactly what a dynamic research team - also composed by allied professionals - needs!" From, Chiara Beccaluva, PT - Italy.
Dear Maria Emerson, Editorial Coordinator, we have deeply appreciated the professionalism demonstrated by the International Journal of Clinical Case Reports and Reviews. The reviewers have extensive knowledge of our field and have been very efficient and fast in supporting the process. I am really looking forward to further collaboration. Thanks. Best regards, Dr. Claudio Ligresti
